The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
We are calling this the ‘medical bypass’,” says Dr. Dimitris Papamargaritis, an associate professor and honorary consultant in diabetes and endocrinology at the University of Leicester. “We’re using a combination of gut hormones to mimic the effectiveness of bariatric surgery. Anti-obesity therapeutic landscape. compared to a 5.1%
105 
Let's personalize your content